Zaltoprofen

DB06737

small molecule experimental

Deskripsi

A non-steroidal anti-inflammatory drug approved for use in Japan in 1993.

Struktur Molekul 2D

Berat 298.36
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1556 Data
Amlodipine The metabolism of Zaltoprofen can be decreased when combined with Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Zaltoprofen.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Zaltoprofen.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Zaltoprofen.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Zaltoprofen.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Zaltoprofen.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Zaltoprofen.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Zaltoprofen.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Zaltoprofen.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Zaltoprofen.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Zaltoprofen.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Zaltoprofen.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Zaltoprofen.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Zaltoprofen.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Zaltoprofen.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Zaltoprofen.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Zaltoprofen.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Zaltoprofen.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Zaltoprofen.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Zaltoprofen.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Zaltoprofen.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Zaltoprofen.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Zaltoprofen.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Zaltoprofen.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Zaltoprofen.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Zaltoprofen.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Zaltoprofen.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Zaltoprofen.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Zaltoprofen.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Zaltoprofen.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Zaltoprofen.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Zaltoprofen.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Zaltoprofen.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Zaltoprofen.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Zaltoprofen.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Zaltoprofen.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Zaltoprofen.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Zaltoprofen.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Zaltoprofen.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Zaltoprofen.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Zaltoprofen.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Zaltoprofen.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Zaltoprofen.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Zaltoprofen.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Zaltoprofen.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Zaltoprofen.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Zaltoprofen.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Zaltoprofen.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Zaltoprofen.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Zaltoprofen.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Zaltoprofen.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Zaltoprofen.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Zaltoprofen.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Zaltoprofen.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Zaltoprofen.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Zaltoprofen.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Zaltoprofen.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Zaltoprofen.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Zaltoprofen.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Zaltoprofen.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Zaltoprofen.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Zaltoprofen.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Zaltoprofen.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Zaltoprofen.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Zaltoprofen.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Zaltoprofen.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Zaltoprofen.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Zaltoprofen.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Zaltoprofen.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Zaltoprofen.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Zaltoprofen.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Zaltoprofen.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Zaltoprofen.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Zaltoprofen.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Zaltoprofen.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Zaltoprofen.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Zaltoprofen.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Zaltoprofen.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Zaltoprofen.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Zaltoprofen.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Zaltoprofen.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Zaltoprofen.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Zaltoprofen.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Zaltoprofen.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Zaltoprofen.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Zaltoprofen.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Zaltoprofen.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Zaltoprofen.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Zaltoprofen.
Indacaterol The risk or severity of hypertension can be increased when Indacaterol is combined with Zaltoprofen.
Rotigotine The risk or severity of hypertension can be increased when Rotigotine is combined with Zaltoprofen.
Amibegron The risk or severity of hypertension can be increased when Amibegron is combined with Zaltoprofen.
Naluzotan The risk or severity of hypertension can be increased when Naluzotan is combined with Zaltoprofen.
Cariprazine The risk or severity of hypertension can be increased when Cariprazine is combined with Zaltoprofen.
Mianserin The risk or severity of hypertension can be increased when Mianserin is combined with Zaltoprofen.
Pizotifen The risk or severity of hypertension can be increased when Pizotifen is combined with Zaltoprofen.
Solabegron The risk or severity of hypertension can be increased when Solabegron is combined with Zaltoprofen.
Asenapine The risk or severity of hypertension can be increased when Asenapine is combined with Zaltoprofen.
Esmirtazapine The risk or severity of hypertension can be increased when Esmirtazapine is combined with Zaltoprofen.
Vilazodone The risk or severity of hypertension can be increased when Vilazodone is combined with Zaltoprofen.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 16473424
    Hirate K, Uchida A, Ogawa Y, Arai T, Yoda K: Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors. Neurosci Res. 2006 Apr;54(4):288-94. Epub 2006 Feb 13.

Contoh Produk & Brand

Produk: 0 • International brands: 10
International Brands
  • Borbit — Yoshindo
  • Peleton — Towa Yakuhin
  • Peon — Zeria Shinyaku
  • Salafapinon — Choseido Pharmaceutical
  • Soleng — Kyorin Rimedio
  • Soleton — CJ Cheiljedang
  • Soluirubin — Taiyo Pharmaceutical
  • Zaltoprofen Tatsumi Kagaku — Tatsumi Kagaku
  • Zatferon — Sawai Seiyaku
  • Zyrogen — Yoo Young

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul